A newly published study has unveiled a surprising immunometabolic interaction that dampens heat production in fat tissue. Researchers led by Tang et al. have identified that itaconate, a metabolite produced by macrophages, acts as a potent negative regulator of thermogenesis in adipose tissue. This discovery challenges previous assumptions about immune cell roles in metabolic regulation and opens doors to novel strategies for obesity and metabolic disorder management.
Thermogenesis in adipose tissue, particularly brown and beige fat, is a critical physiological process that helps maintain body temperature and regulate energy expenditure. Traditionally, this heat-generating function has been attributed largely to adipocytes themselves, modulated by nervous and hormonal signals. However, the emerging field of immunometabolism highlights that immune cells residing within fat play crucial yet intricate roles.
The researchers found that macrophages within adipose tissue synthesize itaconate—a molecule known for its anti-inflammatory properties—via the enzyme immune-responsive gene 1 (IRG1). By employing genetic and pharmacological manipulations in mouse models, the team demonstrated that itaconate significantly suppresses the expression of uncoupling protein 1 (UCP1), a key driver of thermogenic activity in fat cells. This suppression leads to a notable decrease in energy dissipation as heat.
Mechanistically, itaconate influences cellular metabolism by modulating the tricarboxylic acid cycle and reactive oxygen species production, which in turn affect signaling pathways crucial for activating thermogenesis. The study highlights that macrophage-derived itaconate creates an immunometabolic checkpoint that restrains excessive energy expenditure under specific physiological or pathological conditions.
Importantly, the research not only elucidates a direct molecular link between immune cells and fat thermogenesis but also points to potential therapeutic implications. Targeting itaconate production or its downstream effects could enhance thermogenic capacity, offering novel avenues for combating obesity, metabolic syndrome, and related disorders.
The findings also underscore the complexity of tissue-specific immune-metabolic crosstalk. While macrophages have been considered beneficial for maintaining homeostasis and facilitating adipose tissue remodeling, this study reveals a more nuanced role—balancing energy output through metabolic signaling.
Beyond basic science, these insights could inspire drug development focused on modulating itaconate pathways to harness the body’s own thermogenic machinery. Moreover, since itaconate is linked with anti-inflammatory responses, fine-tuning its activity may enable simultaneous control over metabolic health and inflammation.
As obesity rates continue to rise globally, understanding the precise mechanisms controlling energy balance is paramount. This groundbreaking work places macrophage-derived metabolites at the center of adipose tissue thermogenic regulation, potentially transforming future metabolic disease treatments.
In summary, the discovery that macrophage-generated itaconate acts as an intrinsic brake on adipose thermogenesis reveals a novel immunometabolic circuit. This work not only expands our comprehension of fat tissue biology but also holds promise for innovative interventions aimed at metabolic health through immune modulation.
Subject of Research: Regulation of adipose tissue thermogenesis by macrophage-derived itaconate
Article Title: Macrophage-derived itaconate is a negative regulator of adipose tissue thermogenesis
Article References:
Tang, J., Pernes, G., Nakagaki, B. et al. Macrophage-derived itaconate is a negative regulator of adipose tissue thermogenesis. Nat Metab (2026). https://doi.org/10.1038/s42255-026-01572-2
Image Credits: AI Generated
DOI: https://doi.org/10.1038/s42255-026-01572-2
